Cargando…
Incidence of Atypical Femoral Fractures in Patients on Osteoporosis Therapy—A Registry‐Based Cohort Study
Atypical femoral fractures (AFFs) have been reported in patients taking bisphosphonates (BPs) for osteoporosis therapy but also in patients with no exposure to these drugs. In contrast, less is known about the incidence of AFFs in patients taking denosumab. This registry‐based cohort study analyzed...
Autores principales: | Everts‐Graber, Judith, Bonel, Harald, Lehmann, Daniel, Gahl, Brigitta, Häuselmann, HansJörg, Studer, Ueli, Ziswiler, Hans‐Rudolf, Reichenbach, Stephan, Lehmann, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549725/ https://www.ncbi.nlm.nih.gov/pubmed/36248270 http://dx.doi.org/10.1002/jbm4.10681 |
Ejemplares similares
-
Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study
por: Everts-Graber, Judith, et al.
Publicado: (2023) -
Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study
por: Everts-Graber, Judith, et al.
Publicado: (2023) -
Correction: Clinical Value of Prognostic Instruments to Identify Patients with an Increased Risk for Osteoporotic Fractures: Systematic Review
por: Steurer, Johann, et al.
Publicado: (2011) -
Clinical Value of Prognostic Instruments to Identify Patients with an Increased Risk for Osteoporotic Fractures: Systematic Review
por: Steurer, Johann, et al.
Publicado: (2011) -
Surveillance of atypical femoral fractures in a nationwide fracture register
por: BÖGL, Hans Peter, et al.
Publicado: (2022)